A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients

被引：0
|
作者：
Ketter, TA
Graham, J
Thompson, T
Nanry, K
机构：
[1] Stanford Univ, Dept Psychiat, Palo Alto, CA 94304 USA
[2] GlaxoSmithKline Inc, Neurosci MDC, Res Triangle Pk, NC USA
来源：
EPILEPSIA | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [1] A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients
    Graham, JA
    Ketter, TA
    Roberts, J
    DeVeaugh-Geiss, AM
    Thompson, TR
    [J]. BIPOLAR DISORDERS, 2005, 7 : 62 - 62
  • [2] Aripiprazole therapy in 20 older adults with bipolar disorder: A 12-week, open-label trial
    Sajatovic, Martha
    Coconcea, Nicoleta
    Ignacio, Rosalinda V.
    Blow, Frederic C.
    Hays, Robert W.
    Cassidy, Kristin A.
    Meyer, William J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (01) : 41 - 46
  • [3] A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
    Takekita, Yoshiteru
    Kato, Masaki
    Wakeno, Masataka
    Sakai, Shiho
    Suwa, Azusa
    Nishida, Keiichiro
    Okugawa, Gaku
    Kinoshita, Toshihiko
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 110 - 114
  • [4] Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
    Morillas-Arques, Piedad
    Ma Rodriguez-Lopez, Carmen
    Molina-Barea, Rocio
    Rico-Villademoros, Fernando
    Calandre, Elena P.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [5] Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
    Piedad Morillas-Arques
    Carmen Ma Rodriguez-Lopez
    Rocio Molina-Barea
    Fernando Rico-Villademoros
    Elena P Calandre
    [J]. BMC Musculoskeletal Disorders, 11
  • [6] A 12-Week, Open-Label Study Evaluating Sodium Oxybate (SXB) in Patients with Narcolepsy
    Mamelak, Mortimer
    Swick, Todd
    Emsellem, Helene
    Montplaisir, Jacques
    Lai, Chinglin
    Black, Jed
    [J]. ANNALS OF NEUROLOGY, 2014, 76 : S131 - S132
  • [7] The Efficacy and Safety of Lacosamide for Bipolar Depression A 12-Week Open-Label Pilot Trial
    Kishi, Taro
    Nomura, Ikuo
    Sakuma, Kenji
    Okuya, Makoto
    Oya, Kazuto
    Iwata, Nakao
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (02) : 204 - 206
  • [8] Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Takai, Kentaro
    Higuchi, Teruhiko
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2683 - 2695
  • [9] A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression
    McElroy, SL
    Zarate, CA
    Cookson, J
    Suppes, T
    Huffman, RF
    Greene, P
    Ascher, J
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (02) : 204 - 210
  • [10] A 12-WEEK OPEN-LABEL EXTENSION STUDY TO ASSESS THE EFFICACY AND SAFETY OF COMBINATION OF TOLTERODINE AND PILOCARPINE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER AFTER 12-WEEK RANDOMIZED CONTROLLED STUDY
    Lee, K.
    Ko, K. J.
    Lee, J. Z.
    Oh, S.
    Kim, H. G.
    Min, K. S.
    Hong, J. Y.
    Noh, J. H.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S422 - S423
12345